Cited by 940Autism Spectrum Disorder ResearchTryptophan and brain disordersChild Nutrition and Feeding Issues

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome

Open access
Ashwood, Paul, Krakowiak, Paula, Hertz-Picciotto, Irva, Hansen, Robin, Pessah, Isaac, Van de Water, Judy·2011·Brain, Behavior, and Immunity

Abstract

Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. A potential role for immune dysfunction has been suggested in ASD. To test this hypothesis, we investigated evidence of differential cytokine release in plasma samples obtained from 2 to 5 year-old children with ASD compared with age-matched typically developing (TD) children and children with developmental disabilities other than autism (DD). Participants were recruited as part of the population based case-control CHARGE (Childhood Autism Risks from Genetics and Environment) study and included: 97 participants with a confirmed diagnosis of ASD using standard assessments (DSM IV criteria and ADOS, ADI-R), 87 confirmed TD controls, and 39 confirmed DD controls. Plasma was isolated and cytokine production was assessed by multiplex Luminex™ analysis. Observations indicate significant increases in plasma levels of a number of cytokines, including IL-1β, IL-6, IL-8 and IL-12p40 in the ASD group compared with TD controls (p<0.04). Moreover, when the ASD group was separated based on the onset of symptoms, it was noted that the increased cytokine levels were predominantly in children who had a regressive form of ASD. In addition, increasing cytokine levels were associated with more impaired communication and aberrant behaviors. In conclusion, using larger number of participants than previous studies, we report significantly shifted cytokine profiles in ASD. These findings suggest that ongoing inflammatory responses may be linked to disturbances in behavior and require confirmation in larger replication studies. The characterization of immunological parameters in ASD has important implications for diagnosis, and should be considered when designing therapeutic strategies to treat core symptoms and behavioral impairments of ASD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbi.2010.08.003

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated plasma cytokine levels (IL-1β, IL-6, IL-12p40, TNFα), altered immunoglobulin levels, elevated complement proteins, and increased chemokine levels (CCL2, CCL5, CCL11) are reported in the plasma of young children with autistic disorder compared with matched typically developing children.

    “Elevated plasma cytokine levels (IL-1β, IL-6, IL-12p40 and TNFα) [82–84], altered immunoglobulin levels [85, 86], elevated levels of complement proteins [87], and increased chemokine levels (CCL2, CCL5 and CCL11) [88] are reported in the plasma of young children with AD compared with matched typically developing children.”
  • Elevations in IL-1β, IL-6, IL-8 and IL-12p40 are specifically associated with a regressive form of ASD and more impaired stereotypical behaviours, and elevations in CCL2, CCL5 and eotaxin are associated with higher aberrant behaviour scores and more impaired development.

    “Elevations in IL-1β, IL-6, IL-8, IL-12p40 are specifically associated with a regressive form of ASD and more impaired stereotypical behaviours, and elevations in the chemokines C-C motif chemokine 2 (CCL2), CCL5 and eotaxin are associated with higher aberrant behaviour scores and more impaired development120.”
  • These changes include increases in IL-1β, IL-6, IL-8, IL-12p40 and GM-CSF, and decreases in IL-10 and TGF-β.

    “These changes include increases in IL-1β, IL-6, IL-8, IL-12p40 and granulocyte-macrophage colony-stimulating factor (GM-CSF), which are generally considered to be ‘pro-inflammatory’, and decreases in IL-10 and transforming growth factor-β (TGF-β), which are generally considered to be ‘anti-inflammatory’115–120.”
  • Children with ASD have elevated levels of pro-inflammatory cytokines including IL-6, TNF-α, and IFN-γ in different tissues.

    “Furthermore, evidence suggests that children with ASD have elevated levels of pro-inflammatory cytokines including, interleukin 6 (IL–6), tumour necrosis factor alpha (TNF–α), and interferon gamma (IFN-γ) in different tissues [3,4,5,6,7].”
  • Increased cytokines have been reported in association with a regressive autism phenotype with significant communication challenges and aberrant behaviors.

    “An increase in inflammatory cytokines has been reported previously in ASD, and increased cytokines have been reported in association with a regressive autism phenotype with significant communication challenges and aberrant behaviors.56, 57”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J.
Affiliations
  • University of California Davis Medical Center (US)
  • University of California, Davis (US)
Corresponding author
Ashwood, Paul
Venue
Brain, Behavior, and Immunity
Publisher
Elsevier BV
Published
2011-01
Volume
25
Issue
1
Pages
40-45
ISSN
0889-1591 (ISSN-L)
OpenAlex
W2152612457
Cited by
940
References
47
Citations by year
2026: 67 · 2025: 75 · 2024: 92 · 2023: 61 · 2022: 77 · 2021: 64 · 2020: 75 · 2019: 65 · 2018: 63 · 2017: 56 · 2016: 57 · 2015: 36 · 2014: 35 · 2013: 48 · 2012: 39
FWCI
21.62
Type
journal article
Language
en
Open access
Locations
  • Brain Behavior and Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Environmental Health Sciences (R01ES015359, P01ES011269)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, plasma cytokines, immune dysfunction, inflammation, IL-1β, interleukin-6, interleukin-8, interleukin-12p40, regressive autism, communication disorders, aberrant behavior, developmental disabilities, children, CHARGE study
MeSH terms
Child Behavior, Child Behavior Disorders, Child Development Disorders, Pervasive, Child, Preschool, Communication, Female, Humans, Male, Neuropsychological Tests, Regression Analysis, Cytokines, Diagnostic and Statistical Manual of Mental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review